The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells (2021)
- Authors:
- Almeida, Luciana Yamamoto de
- Martins, Diego A. Pereira
- Weinhäuser, Isabel
- Ortiz, César
- Cândido, Larissa A.
- Lange, Ana Paula
- Abreu, Nayara F. de
- Mendonza, Sílvia E. S.
- Wagatsuma, Virgínia M. de Deus
- Nascimento, Mariane C. do
- Paiva, Helder H.
- Alves-Paiva, Raquel M.
- Bonaldo, Camila C. O. M.
- Nascimento, Daniele C.
- Alves-Filho, José Carlos
- Scheucher, Priscila S.
- Lima, Ana Silvia Gouvêa de
- Schuringa, Jan Jacob
- Ammantuna, Emanuele
- Ottone, Tiziana
- Noguera, Nelida I.
- Araujo, Cleide L.
- Rego, Eduardo M.
- USP affiliated authors: NASCIMENTO, DANIELE CARVALHO BERNARDO - FMRP ; ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; SCHEUCHER, PRISCILA SANTOS - FMRP ; YAMADA, ANA SILVIA GOUVÊA LIMA - FMRP ; REGO, EDUARDO MAGALHÃES - FM ; ALMEIDA, LUCIANA YAMAMOTO DE - FMRP ; MARTINS, DIEGO ANTONIO PEREIRA - FMRP ; WEINHÄUSER, ISABEL - FMRP ; NASCIMENTO, DANIELE CARVALHO BERNARDO - FMRP
- Unidades: FMRP; FM
- DOI: 10.3389/fonc.2021.686445
- Subjects: LEUCEMIA; CÉLULAS
- Keywords: Epidermal growth factor receptor (EGFR); Erlotinib; Gefitinib; All-trans retinoic acid (ATRA); Acute promyelocytic leukemia (APL); ATRA-resistance; ATO-resistance; Arsenic trioxide (ATO)
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Frontiers in Oncology
- ISSN: 2234-943X
- Volume/Número/Paginação/Ano: v. 11, art. 686485, 2021
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
ALMEIDA, Luciana Yamamoto de et al. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells. Frontiers in Oncology, v. 11, 2021Tradução . . Disponível em: https://doi.org/10.3389/fonc.2021.686445. Acesso em: 18 abr. 2024. -
APA
Almeida, L. Y. de, Martins, D. A. P., Weinhäuser, I., Ortiz, C., Cândido, L. A., Lange, A. P., et al. (2021). The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells. Frontiers in Oncology, 11. doi:10.3389/fonc.2021.686445 -
NLM
Almeida LY de, Martins DAP, Weinhäuser I, Ortiz C, Cândido LA, Lange AP, Abreu NF de, Mendonza SES, Wagatsuma VM de D, Nascimento MC do, Paiva HH, Alves-Paiva RM, Bonaldo CCOM, Nascimento DC, Alves-Filho JC, Scheucher PS, Lima ASG de, Schuringa JJ, Ammantuna E, Ottone T, Noguera NI, Araujo CL, Rego EM. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 abr. 18 ] Available from: https://doi.org/10.3389/fonc.2021.686445 -
Vancouver
Almeida LY de, Martins DAP, Weinhäuser I, Ortiz C, Cândido LA, Lange AP, Abreu NF de, Mendonza SES, Wagatsuma VM de D, Nascimento MC do, Paiva HH, Alves-Paiva RM, Bonaldo CCOM, Nascimento DC, Alves-Filho JC, Scheucher PS, Lima ASG de, Schuringa JJ, Ammantuna E, Ottone T, Noguera NI, Araujo CL, Rego EM. The combination of gefitinib with ATRA and ATO induces myeloid differentiation in acute promyelocytic leukemia resistant cells [Internet]. Frontiers in Oncology. 2021 ; 11[citado 2024 abr. 18 ] Available from: https://doi.org/10.3389/fonc.2021.686445 - O papel das células T reguladoras no desenvolvimento da imunossupressão durante a sepse grave experimental
- Participação da interleucina-33 e citocinas do tipo 2 na ativação alternativa de macrófagos e estabelecimento da imunossupressão induzida pela sepse
- Interleukin-8 is not a predictive biomarker for the development of the acute promyelocytic leukemia differentiation syndrome
- CCAAT/enhancer-binding protein alpha (CEBPA) gene haploinsufficiency does not alter hematopoiesis or induce leukemia in Lck-CALM/AF10 transgenic mice
- Overexpression of KMT2E is associated with lower ROS generation with arsenic trioxide treatment and higher granulocytic differentiation rate in response to atra-based treatment in acute promyelocytic leukemia cell lines
- ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype
- CCR2-deficient mice are protected to sepsis by the disruption of the inflammatory monocytes emigration from the bone marrow
- An M2-polarized macrophage microenvironment drives leukemogenesis and poor prognosis in acute myeloid leukemia
- Pharmacological IRS1/2 inhibition induces apoptosis in BCR-ABL1T315I mutant cells
- Riboflavin did not provide anti-inflammatory or antioxidant effects in an experimental model of sepsis
Informações sobre o DOI: 10.3389/fonc.2021.686445 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
